ReviewMicroorganisms2022
Human Granulocytic Anaplasmosis-A Systematic Review of Published Cases.
Review in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
56 citing papers in PubMed, 69 citations in OpenAlex.
- Cardiovascular Complications of Anaplasmosis: A Case of Acute Pulmonary Embolism and Literature Review.Infectious disease reports · 2026Article
- Cerebrospinal Fluid Findings among Patients with Anaplasmosis and Central Nervous Involvement, Minnesota and Wisconsin, USA.Emerging infectious diseases · 2026Article
- An in-house nucleic acid test for detection of Anaplasma phagocytophilum in whole blood donor samples.Transfusion · 2026Article
- Comparative Clinical Characteristics of ICU and Non-ICU Hospitalized Patients With Human Anaplasmosis.Open forum infectious diseases · 2026Article
- Article
- Trends in Anaplasmosis Over the Past Decade: A Review of Clinical Features, Laboratory Data, and Outcomes.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
- Tick-Borne Co-Infection in Lyme Disease: Clinical Impact, Diagnostic Challenges, and Therapeutic Perspectives.Microorganisms · 2026Review
- Article
- An imported case of human granulocytic anaplasmosis presenting with altered mental status: A case report.IDCases · 2026Article
- Severe Thrombocytopenia and New Right Bundle Branch Block in Human Granulocytic Anaplasmosis: A Case Report.Journal of Brown hospital medicine · 2026Article
- Article
- Fatal Ehrlichia muris eauclairensis Infection in Liver Transplant Recipient, Minnesota, USA.Emerging infectious diseases · 2026Article
- Mitochondrial Dysfunction inTransboundary and emerging diseases · 2026Review
- Retrospective Multicenter Study of Human Granulocytic Anaplasmosis, France, 2012-2024.Emerging infectious diseases · 2025Article
- Article
- Anaplasmosis: Emerging threat in Canada.Canadian family physician Medecin de famille canadien · 2025Review
- Case report: anaplasma-related myocardial damage in a dog.BMC veterinary research · 2025Article
- Infections by Ehrlichia spp., Anaplasma spp. and Babesia spp. In Puerto Ordaz, Bolívar, VenezuelaBiomedica : revista del Instituto Nacional de Salud · 2025Article
- Seroprevalence ofMicroorganisms · 2025Article
- Impact of Human Granulocytic Anaplasmosis in Spain from 1997 to 2022.Tropical medicine and infectious disease · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 6 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.